Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
Vol. 15, No. 12, 2016, pp. 2739-2743
Bioline Code: pr16361
Full paper language: English
Document type: Research Article
Document available free of charge
Tropical Journal of Pharmaceutical Research, Vol. 15, No. 12, 2016, pp. 2739-2743
© Copyright 2016 - Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria.
Role of glabridin in maintaining residual kidney function in dialysis patients|
Liu, Yun-Qi & Zhang, Wei-Qun
Purpose: To demonstrate the effect of glabridin on peritoneal function and residual renal function (RRF)
in peritoneal dialysis (PD) patients.
Methods: Twenty five patients (age range, 24 - 58 years) with a glomerular filtration rate of above 2
mL/min/1.73 m2 and on PD were subjected to glabridin therapy. The patients were treated daily with
glabridin (30 mg) for 6 months. The baseline parameters for serum high-sensitivity C-reactive protein
(hs-CRP), vascular endothelial growth factor (VEGF), and transforming growth factor β (TGF-β) were
compared with those found after 6 months of glabridin treatment. In addition, end-to-initial dialysate
concentration of glucose (D4/D0 glucose), dialyzer clearance of urea (K), dialysis time (t), volume of
distribution of urea (V), peritoneal transport status as well as dialysate cancer antigen 125 (CA125)
were also compared.
Results: The results revealed a significant increase in mean dialysate CA125 after glabridin treatment
(25.6 ± 2.7 U/mL) compared with baseline value (19.7 ± 3.2 U/mL). However, serum hs-CRP, VEGF,
TGF-β, CTGF, daily ultrafiltration, D4/D0 glucose, Kt/V, and peritoneal transport status remained
unaffected. Residual glomerular filtration rate in all the patients decreased. Glabridin treatment also led
to a decrease in the decline of peritoneal function, suppression of elevation of profibrotic markers, and
increased mesothelial cell mass in PD patients.
Conclusion: Thus, glabridin is a potent candidate for the treatment of residual kidney function in
Glabridin; Residual renal function; Peritoneal function; Dialysate; Profibrotic markers; Mesothelial cell mass; Glomerular filtration rate
Alternative site location: http://www.tjpr.org